This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
Finerenone is a medication containing an active component called Finerenone. It falls under the category of nonsteroidal mineralocorticoid receptor antagonists (MRAs). Its purpose is to address conditions associated with imbalanced levels of mineralocorticoid hormones, specifically aldosterone, within the body. The primary usage of this medication is for the treatment of chronic kidney disease (CKD) in individuals diagnosed with type 2 diabetes. It aids in lowering the likelihood of kidney disease advancement and mitigates the risk of cardiovascular incidents, such as heart failure, in these patients. The initial approval date for finerenone by the U.S. Food and Drug Administration (FDA) was May 26, 2021.
Mechanism of Action of undefined
Finerenone is a selective nonsteroidal mineralocorticoid receptor antagonist (MRA) that blocks the effects of aldosterone, a hormone involved in fluid balance and blood pressure regulation. Inhibiting mineralocorticoid receptors reduces sodium and water retention, prevents potassium excretion, and provides therapeutic benefits in chronic kidney disease, including slowing disease progression, reducing cardiovascular risk, and controlling blood pressure.
Uses of undefined
Finerenone is used in the treatment of Chronic kidney disease (CKD) with type 2 diabetes.
undefined Drug administaration and Dosage available
To use Finerenone, follow your healthcare provider's prescribed dosage and instructions. Take the medications as directed, usually orally, with or without food. Do not skip doses or stop taking them without consulting your healthcare provider. Consult your healthcare provider or pharmacist for guidance if you have any questions or concerns.
Warnings, Precautions and Side Effects of undefined
Finerenone comes with several warnings. These include the risk of hyperkalemia (high potassium levels), caution in patients with renal impairment, the potential for hypotension (low blood pressure), contraindication in severe liver impairment, the possibility of drug interactions, the need to be cautious in patients with adrenal insufficiency, and the recommendation to avoid its use during pregnancy and breastfeeding. Additionally, finerenone may cause electrolyte imbalances, exacerbate heart failure, affect hormone levels, and can rarely lead to hypersensitivity reactions.
Discussing these warnings with your healthcare provider to ensure these medications' safe and appropriate use is essential. When using Finerenone, it is important to adhere to the prescribed dosage and follow the instructions provided by your healthcare provider. Before starting treatment, inform your healthcare provider about any medical conditions, allergies, or medications you are taking.
Regular monitoring of liver function and kidney function is advised. If you experience symptoms of a hypersensitivity reaction, such as fever, rash, or respiratory symptoms, discontinue the medication and seek immediate medical attention. Avoid alcohol and be cautious when driving or operating machinery, as these medications may cause dizziness or drowsiness. Consult your healthcare provider before changing your treatment regimen or starting new medications.
Common side effects of finerenone may include hyperkalemia (high potassium levels), dizziness, diarrhea, and hypotension (low blood pressure). Hyperkalemia is a potential concern due to the mechanism of action of finerenone as a mineralocorticoid receptor antagonist.
Word Of Advice
To ensure proper usage of Finerenone, adhere to the recommended dosage and follow the instructions provided. If you are currently pregnant, planning a pregnancy, or breastfeeding, it is crucial to consult your healthcare provider about this medication's potential risks and benefits. Generally, this medicine is not recommended during pregnancy and breastfeeding. Unless advised otherwise by your healthcare provider, it is advisable to restrict the intake of high-potassium foods like bananas, oranges, tomatoes, and salt substitutes. Some individuals may experience changes in mood or symptoms of depression while taking this medication. The use of this medication in both elderly individuals and children requires special consideration. Adherence and open communication ensure the safe use of this medication.
Frequently Asked Question
1. Glenmark Pharmaceuticals Europe Limited, Electronic Medicines Compendium, [Revised on Feb 2021] [Accessed on 27th May 2023], https://www.medicines.org.uk/emc/files/pil.9939.pdf
2. Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.